secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001558370-24-008898
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Coherus stockholders elect directors, approve say-on-pay and equity plan amendment
--------------------------------------------------------------------------------

- Elected Class I directors: Newcomer (48.3M for), Newton (47.2M for), Tzoumakas (46.1M for).
- Ratified Ernst & Young as auditor for FY2024 with 79.8M for, 552K against.
- Advisory say-on-pay approved (40.3M for, 16.5M against, 1.8M abstain).
- Restated 2014 Equity Incentive Award Plan approved (37.6M for, 18.9M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024008898/0001558370-24-008898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024008898/chrs-20240529x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer